PGR and breast carcinoma: By re-examining the phenotype and associated patient outcomes of breast cancer biopsies previously designated as ER−/PR+ with updated techniques, our results suggest that ER−/PR+ tumours are not a reproducible pathological entity, though small sample size precludes definitive conclusions regarding the existence or non-existence of this subtype.